EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,912 Cr | ₹2,668 Cr | ₹3,210 Cr | ₹3,019 Cr | ₹2,965 Cr |
What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹3,912 Cr |
| Mar2025 | ₹2,668 Cr |
| Mar2024 | ₹3,210 Cr |
| Mar2023 | ₹3,019 Cr |
| Mar2022 | ₹2,965 Cr |
How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,912 Cr | 46.62 | |
| Mar2025 | ₹2,668 Cr | -16.89 | |
| Mar2024 | ₹3,210 Cr | 6.34 | |
| Mar2023 | ₹3,019 Cr | 1.83 | |
| Mar2022 | ₹2,965 Cr | - | |
Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,375.6 Cr | 5.6% | 27.4% | 72.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 5.6% |
27.4% |
72.5% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses